A
Arjun Sahgal
Researcher at Sunnybrook Health Sciences Centre
Publications - 647
Citations - 18598
Arjun Sahgal is an academic researcher from Sunnybrook Health Sciences Centre. The author has contributed to research in topics: Radiosurgery & Medicine. The author has an hindex of 58, co-authored 551 publications receiving 13438 citations. Previous affiliations of Arjun Sahgal include Princess Margaret Cancer Centre & University of Oklahoma Health Sciences Center.
Papers
More filters
Journal ArticleDOI
Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline.
Stephen Lutz,Lawrence Berk,Eric L. Chang,Edward Chow,Carol A. Hahn,Peter Hoskin,David R. Howell,Andre Konski,Lisa A. Kachnic,Simon S. Lo,Arjun Sahgal,Larry N. Silverman,Charles von Gunten,Ehud Mendel,Andrew D. Vassil,Deborah Watkins Bruner,William F. Hartsell +16 more
TL;DR: Radiotherapy is a successful and time efficient method by which to palliate pain and/or prevent the morbidity of bone metastases and is recommended for surgical decompression and postoperative radiotherapy in highly selected patients with sufficient performance status and life expectancy.
Journal ArticleDOI
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
James Perry,Normand Laperriere,Christopher J. O'Callaghan,Alba A. Brandes,Johan Menten,Claire Phillips,Michael Fay,Michael Fay,Ryo Nishikawa,J. Gregory Cairncross,Wilson Roa,David Osoba,John P. Rossiter,Arjun Sahgal,H Hirte,Florence Laigle-Donadey,Enrico Franceschi,Olivier Chinot,Vassilis Golfinopoulos,L. Fariselli,Antje Wick,Loïc Feuvret,Michael Back,Michael Tills,Chad Winch,Brigitta G. Baumert,Wolfgang Wick,Keyue Ding,Warren P. Mason +28 more
TL;DR: In elderly patients with glioblastoma, the addition of temozolomide to short‐course radiotherapy resulted in longer survival than short‐ Course radiotherapy alone.
Journal ArticleDOI
International Spine Radiosurgery Consortium Consensus Guidelines for Target Volume Definition in Spinal Stereotactic Radiosurgery
Brett Cox,Daniel E. Spratt,Michael Lovelock,Mark H. Bilsky,Eric Lis,Samuel Ryu,Jason P. Sheehan,Peter C. Gerszten,Eric L. Chang,Iris C. Gibbs,Scott G. Soltys,Arjun Sahgal,Joseph O. Deasy,John C. Flickinger,Mubina Quader,Stefan A. Mindea,Yoshiya Yamada +16 more
TL;DR: Consensus recommendations include that the CTV should include abnormal marrow signal suspicious for microscopic invasion and an adjacent normal bony expansion to account for subclinical tumor spread in the marrow space.
Journal ArticleDOI
Blood-Brain Barrier Opening in Primary Brain Tumors with Non-invasive MR-Guided Focused Ultrasound: A Clinical Safety and Feasibility Study
Todd G. Mainprize,Nir Lipsman,Nir Lipsman,Yuexi Huang,Ying Meng,Ying Meng,Allison Bethune,Sarah Ironside,Chinthaka Heyn,Ryan Alkins,Maureen Trudeau,Arjun Sahgal,Arjun Sahgal,James Perry,James Perry,Kullervo Hynynen,Kullervo Hynynen +16 more
TL;DR: In this article, the MRgFUS with intravenously injected microbubbles can temporarily and repeatedly disrupt the blood-brain barrier (BBB) in a targeted fashion, without open surgery.
Journal ArticleDOI
Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis.
Arjun Sahgal,Hidefumi Aoyama,Martin Kocher,Binod Neupane,Sandra Collette,Masao Tago,Prakesh Shaw,Joseph Beyene,Eric L. Chang +8 more
TL;DR: For patients ≤50 years of age, SRS alone favored survival, in addition, the initial omission of WBRT did not impact distant brain relapse rates, and S RS alone may be the preferred treatment for this age group.